WESTMINSTER, Colo., Sept. 16, 2013 /PRNewswire/ -- Surefire Medical, Inc., the developer of a brand new class of infusion systems designed to maximize direct-to-tumor drug delivery without reflux, ...

WESTMINSTER, Colo.--(BUSINESS WIRE)--Surefire Medical, Inc. today announced that the company’s new Precision targeted delivery infusion system, for direct-to-tumor embolization procedures, has ...

Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a part of treatment protocols for a large number of clinical indications, and cryopreservation of both autologous ...

A multidisciplinary team with representatives from the departments of medicine, critical care, nursing, health care information systems (HIS), and pharmacy was formed to address the feasibility of ...

The VENUS trial results, which demonstrated a benefit of adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation (AF), are now published. The ...

We developed a computer-controlled intravenous methamphetamine (METH) administration procedure (dynamic infusion), which enables us to compensate for an important pharmacokinetic difference between ...

TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is ...

At the 2025 European Association for the Study of Diabetes (EASD) meeting in Vienna, investigators reported one-year outcomes from FORWARD, a pivotal study of zimislecel (VX-880), an allogeneic, stem ...

Normal pressure hydrocephalus (NPH) is an accumulation of cerebrospinal fluid (CSF) in and around the brain and spinal cord, which can cause symptoms such as abnormal gait, urinary incontinence and ...